Buy Abstet : Abiraterone 250 Mg Tablets 120’S Online

Description

Abstet, marketed under the international brand name Zytiga, is a potent medication manufactured by Biocon Pharma Ltd., designed to combat advanced prostate cancer. Each pack of Abstet contains 120 tablets, with each tablet containing 250 mg of Abiraterone Acetate. With its targeted approach to inhibiting androgen production, Abstet offers hope and support for individuals battling prostate cancer, providing an effective treatment option to improve quality of life and extend survival.

Key Features:

1. Prostate Cancer Treatment: Abstet is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. As a second-line therapy, Abstet offers a valuable option for individuals whose cancer has progressed despite prior hormonal therapies.
2. Androgen Deprivation: Abstet exerts its therapeutic effect by selectively inhibiting the enzyme cytochrome P450 17A1 (CYP17A1), which plays a crucial role in androgen biosynthesis. By blocking this enzyme, Abstet reduces the production of androgens, including testosterone and dihydrotestosterone (DHT), which fuel the growth and progression of prostate cancer cells.
3. Improved Survival: Clinical studies have demonstrated the efficacy of Abstet in improving overall survival and delaying disease progression in men with mCRPC. When used in combination with prednisone or prednisolone, Abstet significantly prolongs progression-free survival and overall survival compared to placebo, offering tangible benefits for patients and their families.
4. Well-Tolerated Profile: Abstet is generally well-tolerated, with the most common adverse effects being manageable and reversible. Common side effects may include fatigue, hypertension, fluid retention, hypokalemia, and elevated liver enzymes. Close monitoring of blood pressure, electrolytes, and liver function is recommended during treatment with Abstet.
5. Convenient Dosage Form: Abstet is available in tablet form, offering convenient and easy administration for patients. Each tablet contains a precise dosage of 250 mg of Abiraterone Acetate, ensuring accurate dosing and consistent therapeutic effect. The pack of 120 tablets provides an ample supply for the duration of treatment.

Indications: Abstet (Abiraterone 250 mg Tablets) is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men who have received prior chemotherapy containing docetaxel.

Directions for Use: Abstet should be taken orally on an empty stomach, at least one hour before or two hours after a meal. The recommended dosage is 1,000 mg (four tablets) once daily in combination with prednisone or prednisolone. Treatment should be continued until disease progression or unacceptable toxicity occurs.

Prescription Required: Please note that a prescription from a qualified healthcare professional is required to purchase Abstet.

Abstet offers a beacon of hope for individuals battling metastatic castration-resistant prostate cancer, providing an effective treatment option to improve outcomes and quality of life. With its targeted mechanism of action, proven efficacy, and trusted manufacturer, Abstet represents a valuable resource in the fight against advanced prostate cancer, empowering patients to face their diagnosis with confidence and resilience.